Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors

NCT01679470 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary or Metastatic Lung Tumors

Interventions

DEVICE: AuroLase Therapy

Sponsor

Nanospectra Biosciences, Inc.